Cyclerion Therapeutics, Inc. (CYCN)
1.35
-0.01
(-0.74%)
USD |
NASDAQ |
Jan 20, 16:00
1.33
-0.02
(-1.48%)
After-Hours: 07:20
Cyclerion Therapeutics Shareholders Equity (Quarterly): 9.538M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
| Oragenics, Inc. | 9.831M |
| NanoViricides, Inc. | 7.175M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.42M |
| Total Liabilities (Quarterly) | 0.877M |
| Current Ratio | 5.775 |